TrianglePIPAC Nab-Paclitaxel (NCT06675136)
PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with stomach cancer that has spread to the lining of the abdomen, called the peritoneum.
The idea: during a short keyhole procedure, spray nab-paclitaxel chemotherapy as a fine pressurized mist inside the abdomen. This is called PIPAC. It is combined with standard second line treatment, paclitaxel and ramucirumab, given by vein.
The study looks at safety, the best dose, and how well it works.
This phase 1 study plans 30 patients. At City of Hope in Duarte, California, Yanghee Woo leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.